Alzheimer's Disease and Dementia
Our work in Alzheimer's Disease and Dementia
-
Using a Digital Neuro Signature to Measure Longitudinal Individual-Level Change in Alzheimer’s Disease: The Altoida Large cohort Study
Conventional neuropsychological assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild cognitive impairment and predicting Alzheimer’s disease risk.
Categorized in -
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
The FDA’s recent approval of the first disease-modifying therapy for Alzheimer’s will fuel the chances of even more breakthroughs.
-
Podcast: The Impact and Economics of Alzheimer’s
Julie Zissimopoulos recently spoke about her research using economic insights to better understand the impact of Alzheimer’s disease on individuals, families, caregivers, and society.
-
Association Between Exenatide Use and Incidence of Alzheimer’s Disease
Exenatide use is associated with a reduced incidence of AD among Medicare beneficiaries aged 65 years or older with type II diabetes.
Categorized in -
Information Session for Schaeffer Center Pilot Funding
Join us on Tuesday, January 12 to learn more about upcoming pilot funding opportunities through Schaeffer Center for Roybal Center for Behavioral Interventions in Aging, CeASES-ADRD and USC Alzheimer’s Disease Resource Center for Minority Aging Health Economics Research.
-
Addressing the Diverse Needs of Unpaid Caregivers Through New Health-Care Policy Opportunities
About 41 million spouses, children, and other relatives have provided unpaid care to a family member aged 50 years or older in the past 12 months
Categorized in -
Health and Social Correlates of Dementia in Oldest‐Old Mexican‐Origin Populations
Substantial gaps in research remain across oldest‐old ethnic populations while the burden of dementia increases exponentially with age among Mexican and Mexican American older adults.
-
TBI and Increased Risk of Non-Alzheimer’s Disease Dementia in Older Male Twins
Several studies have reported an association between traumatic brain injury(TBI) and increased risk of Alzheimer’s disease(AD) and all cause dementia. Considering the heterogeneous genetic and environmental factors that may contribute to development of dementia, co-twin control analyses provide a level of control for confounding factors that is difficult to achieve with other case-control designs.
Categorized in -
Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans
The study provides new insights – the self-reports of survey respondents – into cognitive assessments at annual wellness visits, an area that has been somewhat hidden from view.
Categorized in -
Most Medicare Beneficiaries Say They Don’t Receive Structured Cognitive Assessments at Wellness Visits
The results reinforce the need to evaluate policies and practices around detecting impairment, according to the researchers.